<DOC>
	<DOCNO>NCT00005660</DOCNO>
	<brief_summary>This continue study evaluate long-term safety efficacy oral acitretin open manner treatment psoriasis , cutaneous disorder keratinization , multiple basal cell carcinoma retinoid responsive disease .</brief_summary>
	<brief_title>The Evaluation Oral Acitretin Treatment Psoriasis , Cutaneous Disorders Keratinization , Multiple Basal Cell Carcinomas Other Retinoid Responsive Diseases</brief_title>
	<detailed_description>This continue study evaluate long-term safety efficacy oral acitretin open manner treatment psoriasis , cutaneous disorder keratinization , multiple basal cell carcinoma retinoid responsive disease .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<mesh_term>Basal Cell Nevus Syndrome</mesh_term>
	<mesh_term>Hamartoma Syndrome , Multiple</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Keratoderma , Palmoplantar</mesh_term>
	<mesh_term>Keratoderma , Palmoplantar , Diffuse</mesh_term>
	<mesh_term>Acitretin</mesh_term>
	<criteria>Patients widespread involvement ( e.g . psoriasis patient 10 percent body surface area involve ) severe , recalcitrant localize involvement cutaneous disorder ( e.g . keratoderma palmaris et plantaris ) . Patients ( parent patient le 18 year old ) must advise presently available alternative form therapy . Patient must available agreeable regular follow examination clinic clinical evaluation , blood test , diagnostic xrays possibly skin biopsy . The patient ( parent , guardian , surrogate appropriate ) must give write informed consent protocol , include limitation risk , thoroughly discuss patient ( parent ) . Patients multiple skin cancer xeroderma pigmentosum ( XP ) . No patient persistently abnormal ( SGOT SGPT great 3 time upper limit normal ) liver function test . No patient persistent pretreatment hypertriglyceridemia ( great 300 mg/dl ) . No patient persistently abnormal ( creatinine great 3 time upper limit normal ) renal function test . No patient presence significant neurological , musculoskeletal internal medical disorder may aggravate addition retinoid therapy . Patient must pregnant anticipate event . Because longterm storage etretinate , know teratogen , fertile woman may treat protocol , must skin disease severe recalcitrant standard modality . These woman must also use effective form contraception ( oral contraceptive intrauterine device ) treatment least 3 year post treatment . No patient chronic intake excessive dietary vitamin A ( 25,000 iu/day ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2001</verification_date>
	<keyword>Hypertriglyceridemia</keyword>
	<keyword>Teratogenicity</keyword>
	<keyword>Ichthyosis</keyword>
	<keyword>Darier 's Disease</keyword>
	<keyword>Retinoids</keyword>
	<keyword>Skin</keyword>
	<keyword>Psoriasis</keyword>
	<keyword>Basal cell carcinoma</keyword>
	<keyword>Skin Cancer</keyword>
</DOC>